NeoCore Technology Co., Ltd.

4131

TW0004131008

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-06-03 pm EDT			5-day change	1st Jan Change
32.5 ^TWD	+0.78%		+3.17%	+47.73%

May. 15	NeoCore Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 15	NeoCore Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

DR.Chip Biotechnology Incorporation announced a financing transaction

March 07, 2016

DR.Chip Biotechnology Incorporation (GTSM:4131) announced a private placement of 28,000,0000 shares on March 8, 2016.

Latest news about NeoCore Technology Co., Ltd.

NeoCore Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
NeoCore Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
DR. Chip Biotechnology Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
DR. Chip Biotechnology Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
DR.Chip Biotechnology Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-13	CI
DR.Chip Biotechnology Incorporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
DR.Chip Biotechnology Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
DR.Chip Biotechnology Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
DR.Chip Biotechnology Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-09	CI
DR.Chip Biotechnology Incorporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-18	CI
DR.Chip Biotechnology Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-06	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-12	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-17	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-08	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-12	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-12	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-11	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-11	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-07	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-26	CI
ABICO-Netcom cancelled the acquisition of 20.7% stake in DR.Chip Biotechnology Incorporation.	19-03-12	CI
Dr.Chip Biotechnology Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2018	18-11-12	CI
ABICO-Netcom agreed to acquire 20.7% stake in DR.Chip Biotechnology Incorporation for TWD 70 million.	18-03-12	CI

Chart NeoCore Technology Co., Ltd.

Duration

Period

More charts

NeoCore Technology Co Ltd is a Taiwan-based company mainly engaged in the research and development and production of biological detection chips and the trading of contact lenses of its subsidiaries, as well as the provision of related inspection and technology transfer services. The products include deoxyribonucleic acid / ribonucleic acid (DNA/RNA) sample preparation kits, polymerase chain reaction kits, rapid hybridization equipment, biochips, testing reagents, biological preparations, nucleic acid sequencing detection, biotechnology control hardware and software and related components, biomedical materials, and nutritional supplements. The products are mainly sold domestically and exported to Asia and Europe.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Equipment

	1st Jan change	Capi.
NEOCORE TECHNOLOGY CO., LTD.	+47.73%	39.67M
SHOCKWAVE MEDICAL, INC.	+75.69%	12.57B
PENUMBRA, INC.	-24.12%	7.4B
MASIMO CORPORATION	+10.90%	6.9B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+20.88%	5.79B
GETINGE AB	-16.83%	4.86B
APT MEDICAL INC.	+19.43%	4.27B
ASAHI INTECC CO., LTD.	-18.48%	3.96B
INARI MEDICAL, INC.	-24.00%	2.87B
NOVOCURE LIMITED	+52.88%	2.46B